PDCD1 and neoplasm: The increased numbers of PD-1+CD8+ T cells in tumors suggest that patients contain tumor-specific T cells that can be activated and—before silencing by inhibitory molecules, such as PD-1—exert an antitumor effect, supplementing both radiotherapy and surgery and enhancing survival.